2002
DOI: 10.1002/jcla.10054
|View full text |Cite
|
Sign up to set email alerts
|

Clinical application of the serum 1,5‐anhydroglucitol assay method using glucose 3‐dehydrogenase

Abstract: We attempted to develop a novel serum 1,5-anhydroglucitol (1,5-AG) assay kit using glucose 3-dehydrogenase (G3DH) from Halomonas sp. alpha-15 strain. The major advantages of this method are that the 1,5-AG detection requires a very small amount of G3DH, and the enzyme catalyzes a simple reaction. The analytical performances were acceptable for clinical use operated with a clinical automatic analyzer. The correlation with a commercial assay kit against sera of healthy volunteers was y=0.975x+0.008, r=0.993, Syl… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2005
2005
2018
2018

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 8 publications
(1 citation statement)
references
References 11 publications
0
1
0
Order By: Relevance
“…Other diabetes markers, such as sugar alcohols, 1,5-anhydro-d-glucitol (1,5-AG) (Jeppson et al, 2002), sorbitol (Malone at al., 1980), myo-inositol (Tetsuo et al, 1999) and mannitol (Pikanen, 1996) have also been reported. In particular, 1,5-AG reflects the very early stage (pre-diabetes) of the disease (Jeppson et al, 2002;Chusney et al, 1995;Tanabe et al, 1997;Hamefuji et al, 2002). The composition of these sugar alcohols indicates the characteristic pattern of clinical conditions in diabetic patients (Jeppson et al, 2002;Malone et al, 1980;Tetsuo et al, 1999;Pikanen, 1996;Niwa et al, 1994;Hamefuji et al, 1997).…”
Section: Introductionmentioning
confidence: 95%
“…Other diabetes markers, such as sugar alcohols, 1,5-anhydro-d-glucitol (1,5-AG) (Jeppson et al, 2002), sorbitol (Malone at al., 1980), myo-inositol (Tetsuo et al, 1999) and mannitol (Pikanen, 1996) have also been reported. In particular, 1,5-AG reflects the very early stage (pre-diabetes) of the disease (Jeppson et al, 2002;Chusney et al, 1995;Tanabe et al, 1997;Hamefuji et al, 2002). The composition of these sugar alcohols indicates the characteristic pattern of clinical conditions in diabetic patients (Jeppson et al, 2002;Malone et al, 1980;Tetsuo et al, 1999;Pikanen, 1996;Niwa et al, 1994;Hamefuji et al, 1997).…”
Section: Introductionmentioning
confidence: 95%